Professional Documents
Culture Documents
OBJECTIVES
Explain the importance of glycoproteins in health and disease.
Describe the principal sugars found in glycoproteins.
Describe the major classes of glycoproteins (N-linked, O-linked, and GPI-linked).
Describe the major features of the pathways of biosynthesis and degradation of
glycoproteins.
Explain how many microorganisms, such as influenza virus, attach to cell surfaces
via sugar chains.
BIOMEDICAL IMPORTANCE
The glycoproteins are proteins that contain oligosaccharide chains (glycans)
covalently bound to amino acids;
glycosylation (the enzymic attachment of sugars) is the most frequent
posttranslational modification of proteins.
Many proteins also undergo reversible glycosylation with a single sugar (N-
acetylglucosamine) bound to a serine or threonine residue that is also a site for
reversible phosphorylation. This is an important mechanism of metabolic
regulation.
Nonenzymic attachment of sugars to proteins can also occur, and is referred to
as glycation. This process can have serious pathologic consequences (eg, in
poorly controlled diabetes mellitus).
Glycoproteins are one class of glycoconjugate or complex carbohydrate—
molecules containing one or more carbohydrate chains covalently linked to
protein to form among others, glycoproteins, or proteoglycans or to lipid (to
form glycolipids.
Almost all plasma proteins, and many peptide hormones, are glycoproteins, as
are a number of blood group substances.
Many cell membrane proteins contain substantial amounts of carbohydrate,
and many are anchored to the lipid bilayer by a glycan chain.
Evidence is accumulating that alterations in the structures of glycoproteins and
other glycoconjugates on the surface of cancer cells are important in
metastasis.
Glycoproteins
short
heterooligosaccharide
chain (branched); can be
charged; do not have
repetitive disaccharide
units
Glycosylation Characteristics of Glycoproteins
At ER Lumen At Golgi complex
Glycoproteins contains N-terminal signal sequence Glycoproteins contains O-terminal signal sequence
(N-Glycosylation ) (O-glycosylation)
Or Threonine
Glycoproteins are degraded by lysosomal enzymes (not possible if there is enzyme deficiency)
GLYCOPROTEINS OCCUR WIDELY & PERFORM NUMEROUS
FUNCTIONS
Glycoproteins occur in most organisms, from bacteria to human beings.
o Many viruses also contain glycoproteins, some of which play key roles in
viral attachment to host cells.
The glycoproteins have a wide range of functions; their carbohydrate content
ranges from 1 to over 85% by weight.
The biological information in the sequence and linkages of sugars in glycans differs
from that in DNA, RNA, and proteins in one important respect;
o it is secondary rather than primary information.
o The pattern of glycosylation of a given protein depends on the pattern of
expression of the various glycosyltransferases in the cell that are involved in
glycoprotein synthesis, the affinity of the different glycosyltransferases for
their carbohydrate substrates, and the relative availability of the different
carbohydrate substrates.
o Because of this there is microheterogeneity of glycoproteins, something
that complicates their analysis. Not all of the glycan chains of a given
glycoprotein are complete; some are truncated.
o The information from the sugars is expressed via interactions between the
glycans and proteins such as lectins (see below) or other molecules. These
interactions lead to changes in cellular activity.
EIGHT SUGARS PREDOMINATE IN HUMAN GLYCOPROTEINS
Only eight monosaccharides are commonly found in glycoproteins.
o N-acetylneuraminic acid (NeuAc) is usually found at the termini of
oligosaccharide chains, attached to subterminal galactose (Gal) or N-
acetylgalactosamine (GalNAc) residues.
o The other sugars are usually found in more internal positions.
o Sulfate is often found in glycoproteins, usually attached to galactose, N-
acetylglucosamine, or Nacetylgalactosamine.
an N-linkage (Nacetylglucosamine
to asparagine) a glycosylphosphatidylinositol
(GPI) linkage
Mucins
are glycoproteins that are highly resistant to proteolysis because the density of
oligosaccharide chains makes it difficult for proteases to access the polypeptide
chain.
They help to lubricate and form a protective physical barrier on epithelial
surfaces.
Two distinctive characteristics:
o high content of O-linked oligosaccharides (the carbohydrate content is
generally more than 50%);
o presence of variable numbers of tandem repeats (VNTRs) of peptide
sequence in the center of the polypeptide chain, to which the Oglycan
chains are attached in clusters.
These tandem repeat sequences are rich in serine, threonine, and
proline; indeed, up to 60% of the dietary requirement for threonine
can be accounted for by the synthesis of mucins.
o also contain a number of N-glycan chains.
Both secretory and membrane-bound mucins occur:
Secretory mucins:
o Mucus secreted by the gastrointestinal, respiratory, and reproductive tracts
is a solution containing about 5% mucins.
o Secretory mucins generally have an oligomeric structure, with monomers
linked by disulfide bonds, and hence a very high molecular mass.
o Mucus has a high viscosity and often forms a gel because of its content of
mucins.
o The high content of O-glycans confers an extended structure. This is partly
explained by steric interactions between the N-acetylgalactosamine
moieties and adjacent amino acids, resulting in a chain-stiffening effect, so
that the conformation of mucins often become rigid rods.
o Intermolecular noncovalent interactions between sugars on neighboring
glycan chains contribute to gel formation.
o The high content of N-acetylneuraminic acid and sulfate residues found in
many mucins gives them a negative charge.
Membrane-bound mucins participate in cell–cell interactions, and may also mask
cell surface antigens.
Many cancer cells form large amounts of mucins that mask surface antigens and
protect the cancer cells from immune surveillance.
Mucins also carry cancer-specific peptide and carbohydrate epitopes. Some of
these have been used to stimulate an immune response against cancer cells.
Calnexin. (a) Overall structure of calnexin showing the globular domain with a legume lectin-like β-sandwich fold and the
extended P-domain thought to embrace the glycoprotein substrate (PDB 1JHN). (b) Closeup view of the carbohydrate-
binding binding site with a glucose molecule (green) modeled into it according to the description in reference 35. Selected
residues are labeled.
Various cancer cells are found to synthesize different oligosaccharide chains from
those made in normal cells (eg, greater branching). This is due to cancer cells
expressing different patterns of glycosyltransferases from those in normal cells, as
a result of specific gene activation or repression. The differences in
oligosaccharide chains could affect adhesive interactions between cancer cells and
the normal parent tissue cells, contributing to metastasis.
SOME PROTEINS ARE ANCHORED TO THE PLASMA MEMBRANE BY
GLYCOPHOSPHATIDYL-INOSITOL STRUCTURES
The GPI anchor is preformed in the endoplasmic reticulum, and is then attached to
the protein after ribosomal synthesis is complete.
The primary translation products of GPI-anchored proteins have not only an
amino terminal signal sequence that directs them into the endoplasmic reticulum
during synthesis, but also a carboxy-terminal hydrophobic domain that acts as the
signal for attachment of the GPI anchor.
The first stage in synthesis of the GPI anchor is insertion of the fatty acids of
phosphatidylinositol into the luminal face of the endoplasmic reticulum
membrane, followed by glycosylation, starting with esterification of N-acetyl-
glucosamine to the phosphate group of phosphatidylinositol.
A terminal phosphoethanolamine moiety is added to the completed glycan chain.
The hydrophobic carboxyterminal domain of the protein is displaced by the amino
group of ethanolamine in the transamidation reaction that forms the amide
linkage between the GPI anchor and an aspartate residue in the protein.
SOME PROTEINS UNDERGO RAPIDLY REVERSIBLE GLYCOSYLATION
Many proteins, including nuclear pore proteins, proteins of the cytoskeleton,
transcription factors, and proteins associated with chromatin, as well as nuclear
oncogene proteins and tumor suppressor proteins, undergo rapidly reversible O-
glycosylation with a single sugar moiety, Nacetylglucosamine.
The serine and threonine sites of glycosylation are the same as those of
phosphorylation of these proteins, and glycosylation and phosphorylation occur
reciprocally in response to cellular signaling.
The O-linked N-acetylglucosamine transferase that catalyzes this glycosylation
uses UDP-N-acetylglucosamine as the sugar donor, and has phosphatase activity,
so can directly replace a serine or threonine phosphate with N-acetylglucosamine.
There is no absolute consensus sequence for the reaction, but about half the sites
that are subject to reciprocal glycosylation and phosphorylation are Pro-Val-Ser.
O-linked Nacetylglucosamine transferase is activated by phosphorylation in
response to insulin action, and the N-acetylglucosamine is removed by
Nacetylglucosaminidase, leaving the site available for phosphorylation. Both the
activity and peptide specificity of O-linked Nacetylglucosamine transferase depend
on the concentration of UDP-Nacetylglucosamine. Depending on cell type, up to 2
to 5% of glucose metabolism is by way of the hexosamine pathway leading to
Nacetylglucosamine formation, giving the O-linked N-acetylglucosamine
transferase a role in nutrient sensing in the cell.
Excessive O-glycosylation with N-acetylglucosamine (and hence reduced
phosphorylation) of target proteins is implicated in insulin resistance and glucose
toxicity in diabetes mellitus, as well as neurodegenerative diseases.
ADVANCED GLYCATION END-PRODUCTS (AGEs) ARE IMPORTANT
IN CAUSING TISSUE DAMAGE IN DIABETES MELLITUS
Glycation is the nonenzymic attachment of sugars (mainly glucose) to amino groups of
proteins (and also to other molecules including DNA and lipids), unlike glycosylation
which is enzyme-catalyzed. Initially, glucose forms a Schiff base to the amino terminal of
the protein, which then undergoes the Amadori rearrangement to yield ketoamines
(Figure 46– 5), and further reactions to yield advanced glycation end-products (AGEs).
The overall series of reactions is known as the Maillard reaction, which is involved in the
browning of certain foodstuffs during storage or heating, and provides much of the
flavor of some foods.
Examples:
Leukocyte adhesion deficiency II is a rare condition due to mutations affecting the
activity of a Golgi-located GDP-fucose transporter. The absence of fucosylated
ligands for selectins leads to a marked decrease in neutrophil rolling. Patients
suffer life-threatening recurrent bacterial infections, and also psychomotor and
mental retardation. The condition may respond to oral fucose.
Some of the congenital muscular dystrophies are the result of defects in the
synthesis of glycans in the protein α-dystroglycan. This protein protrudes from the
surface membrane of muscle cells and interacts with laminin-2 (merosin) in the
basal lamina. If the glycans of α-dystroglycan are not correctly formed (as a result
of mutations in genes encoding some glycosyltransferases), this results in
defective interaction of α-DG with laminin.
Examples:
- Human immunodeficiency virus type 1 (HIV-1), the cause of AIDS, attaches to cells
via one of its surface glycoproteins (gp 120) and uses another surface glycoprotein
(gp 41) to fuse with the host cell membrane.
o Antibodies to gp 120 develop during infection by HIV-1, and there has been
interest in using the protein as a vaccine.
One major problem with this approach is that the structure of gp 120 can
change relatively rapidly due to mutations, allowing the virus to escape
from the neutralizing activity of antibodies directed against it.
- Many bacteria that cause diarrhea attach to surface cells of the intestinal mucosa via
glycans present in glycoproteins or glycolipids.
o The attachment of the malarial parasite Plasmodium falciparum to human cells
is mediated by a GPI present on the surface of the parasite.